Latest News & Features
Asia
The Indian Supreme Court has failed to provide the clarity which is craved by practitioners in its latest pronouncement on the controversial Section 3(d), says Jitesh Kumar. 19 February 2014
article
It’s been a long time coming, but perhaps the Brazilian patent office is finally going to deal with the logjam of patent applications, says Gabriel di Blasi. 19 February 2014
Biotechnology
Second and further medical use claims provide companies and patent lawyers with interesting opportunities, as Caroline Pallard explains. 19 February 2014
Big Pharma
Several of the world’s 10 top-selling drugs lose exclusivity this year. LSIPR takes a look at the products, their major competitors, and their manufacturers’ strategies for keeping a grasp of market share. 19 February 2014
Big Pharma
The CJEU has delivered its judgment in three SPC cases, in an attempt to address fundamental issues in the SPC Regulation, as well as uncertainties arising from earlier rulings. Although questions have been answered, others have been raised, say David Carling and Michael Pears. 19 February 2014
Asia-Pacific
Australia’s antitrust regulator has launched proceedings against Pfizer’s Australian arm, accusing it of abusing its power when supplying cholesterol-lowering drug atorvastatin to pharmacies. 18 February 2014
Americas
Novartis has announced it will acquire biotechnology company CoStim for an undisclosed sum. 18 February 2014
Americas
Humanitarian organisation Médecins Sans Frontières has criticised the US for pressuring the Indian government to review its patent policies. 17 February 2014
Biotechnology
Baker & McKenzie LLP has added to its IP team with the appointment of Hiroshi Sheraton as partner in its London office. 17 February 2014
Americas
Myriad and its rival genetic diagnostics company Gene by Gene have agreed to settle their patent infringement case related to BRCA tests. 13 February 2014